Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 EUR)

NET PROFIT (x1000 EUR)

Share

Xellia Pharmaceuticals AS

Closing information (x1000 EUR)

Closing information 2024/12 2023/12 2022/12
Turnover 7,019 More Arrow 7,639 More Arrow 8,454
Financial expenses 0 More Arrow 1 Less Arrow 0
Earnings before taxes 7,280 Less Arrow 4,502 More Arrow 4,949
Total assets 65,956 Less Arrow 65,142 Less Arrow 64,679
Current assets 22,114 Less Arrow 21,707 Less Arrow 20,239
Current liabilities 6,013 Less Arrow 4,842 Less Arrow 1,776
Equity capital 59,700 More Arrow 60,000 More Arrow 62,561
- share capital 18,847 More Arrow 19,862 More Arrow 21,209

Financial ratios

Fiscal year 2024/12 2023/12 2022/12
Solvency 90.5% More Arrow 92.1% More Arrow 96.7%
Turnover per employee
Profit as a percentage of turnover 103.7% Less Arrow 58.9% Less Arrow 58.5%
Return on assets (ROA) 11.0% Less Arrow 6.9% More Arrow 7.7%
Current ratio 367.8% More Arrow 448.3% More Arrow 1139.6%
Return on equity (ROE) 12.2% Less Arrow 7.5% More Arrow 7.9%
Change turnover -230 Less Arrow -278 More Arrow 1,495
Change turnover % -3% Less Arrow -4% More Arrow 21%
Chg. No. of employees
Chg. No. of employees %

Total value of public sale

Fiscal year 2024/12 2023/12 2022/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.